IRVINE, Calif.--(BUSINESS WIRE)--March 27, 2006--In a breakthrough for stem cell research and cellular replacement therapies, PrimeGen Biotech LLC (www.primegenbiotech.com) today announced that this week, its researchers will present data showing the isolation and therapeutic reprogramming of adult human germ line stem cells. Derived from adult stem cells but with the advantageous genetic characteristics of embryonic stem cells, PrimeGen’s PrimeCells(TM) have been successfully transformed into cardio, neuro, osteo and chondrocytes.
